1. Home
  2. LZB vs AMLX Comparison

LZB vs AMLX Comparison

Compare LZB & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo La-Z-Boy Incorporated

LZB

La-Z-Boy Incorporated

HOLD

Current Price

$39.63

Market Cap

1.5B

ML Signal

HOLD

Logo Amylyx Pharmaceuticals Inc.

AMLX

Amylyx Pharmaceuticals Inc.

HOLD

Current Price

$17.90

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LZB
AMLX
Founded
1927
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
LZB
AMLX
Price
$39.63
$17.90
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
9
Target Price
$39.00
$21.56
AVG Volume (30 Days)
743.9K
1.7M
Earning Date
06-16-2026
05-07-2026
Dividend Yield
2.75%
N/A
EPS Growth
5.11
65.46
EPS
2.47
N/A
Revenue
$2,349,433,000.00
$380,786,000.00
Revenue This Year
$1.89
N/A
Revenue Next Year
$2.09
N/A
P/E Ratio
$16.24
N/A
Revenue Growth
N/A
1612.94
52 Week Low
$29.03
$5.98
52 Week High
$44.90
$19.15

Technical Indicators

Market Signals
Indicator
LZB
AMLX
Relative Strength Index (RSI) 55.66 66.78
Support Level $36.31 $12.17
Resistance Level $39.76 $18.61
Average True Range (ATR) 1.73 1.03
MACD -0.01 0.36
Stochastic Oscillator 46.29 78.03

Price Performance

Historical Comparison
LZB
AMLX

About LZB La-Z-Boy Incorporated

La-Z-Boy Inc is a U.S.-based company that manufactures, distributes, and retails upholstery furniture products. It is a producer of reclining chairs and distributors of residential furniture in the U.S. The company chiefly operates in the United States but also has secondary operations in Canada and other countries. The company's reportable segments include the Wholesale segment, which manufactures and imports upholstered furniture; Retail, which sells upholstered and case goods furniture to the end consumer and corporate and others. The majority of the company's revenue is derived from its Wholesale segment.

About AMLX Amylyx Pharmaceuticals Inc.

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.

Share on Social Networks: